Department of Urology, All India Institute of Medical Sciences, New Delhi, India.
J Robot Surg. 2022 Oct;16(5):1123-1131. doi: 10.1007/s11701-021-01348-8. Epub 2022 Jan 3.
We aimed to compare surgical, oncological, and functional outcomes of robot-assisted radical prostatectomy (RARP) in prostate cancer patients with and without prior history of transurethral resection of the prostate (TURP), using a matched cohort analysis. In an IRB-approved protocol, all patients who underwent RARP at our institution between April 2005 and July 2018 with at least 1-year follow-up were included. Among these, patients who had undergone a previous TURP (Group A) were compared with those without TURP (Group B) using the Survival, Continence, and Potency outcomes reporting system. Using propensity score matching for age, PSA and Gleason score, the two cohorts were further subdivided in a 1:2 ratio into Group C (prior TURP from Group A) and Group D (without prior TURP from Group B). Similar comparisons were made between Group C and D. Patients in Group A (n = 40) had lower PSA (p = 0.031) and were more likely to have Gleason grade 1 disease (p = 0.035) than patients in Group B (n = 143). In the propensity-matched group analysis, patients of Group C (n = 38) had higher operative time and blood loss than Group D (n = 76) patients. Group C patients also had lower continence at 3, 6, and 12 months after surgery. However, oncological and potency outcomes were similar in both the groups. We concluded that previous TURP is a predictor for surgical and continence outcomes following RARP. Even though these patients have a potentially lower stage or grade of disease, they are less likely to achieve social continence than men who have not had a previous TURP. This information would be important in counseling them for treatment options.
我们旨在通过匹配队列分析比较有和无经尿道前列腺切除术(TURP)史的前列腺癌患者接受机器人辅助根治性前列腺切除术(RARP)的手术、肿瘤学和功能结果。在一项机构审查委员会批准的方案中,我们机构于 2005 年 4 月至 2018 年 7 月期间对所有接受 RARP 且随访至少 1 年的患者进行了研究。在这些患者中,对先前接受过 TURP(A 组)的患者与未接受 TURP(B 组)的患者使用生存、控尿和勃起功能报告系统进行了比较。通过年龄、PSA 和 Gleason 评分的倾向评分匹配,将两组进一步按 1:2 的比例分为 A 组中的先前 TURP(C 组)和 B 组中无先前 TURP(D 组)。在 C 组和 D 组之间进行了类似的比较。与 B 组(n=143)相比,A 组(n=40)患者的 PSA 较低(p=0.031),且更有可能患有 Gleason 分级 1 疾病(p=0.035)。在倾向评分匹配的组分析中,C 组(n=38)患者的手术时间和失血量均高于 D 组(n=76)患者。C 组患者术后 3、6 和 12 个月的控尿率也较低。然而,两组的肿瘤学和勃起功能结果相似。我们得出结论,先前的 TURP 是 RARP 后手术和控尿结果的预测因素。尽管这些患者的疾病分期或分级可能较低,但与未接受过 TURP 的男性相比,他们更有可能无法实现社会控尿。在为他们提供治疗选择时,这一信息非常重要。